FDA Person
FDAPeter R. Lenahan
View detailed information about Peter R. Lenahan, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 48 inspections of 43 companies, 2016–2019.
Inspections (48)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 13, 2019 | RiconPharma LLC | NAI | Bioresearch Monitoring | #1105217 |
| September 6, 2019 | Merck & Co. Inc | NAI | Bioresearch Monitoring | #1101464 |
| August 9, 2019 | Yair D. Kissin, M.D. | NAI | Bioresearch Monitoring | #1100794 |
| July 23, 2019 | Jonathan Dosik, M.D. | NAI | Bioresearch Monitoring | #1099082 |
| July 2, 2019 | Marc Cohen, M.D. | NAI | Bioresearch Monitoring | #1097502 |
| May 30, 2019 | Colgate-Palmolive Company | VAI | Bioresearch Monitoring | #1091323 |
| May 16, 2019 | Wendy Kozak, DVM | NAI | Bioresearch Monitoring | #1091456 |
| April 25, 2019 | Integrated Medical Development | NAI | Bioresearch Monitoring | #1088948 |
| April 11, 2019 | Jonathan C Goodwin, DVM | NAI | Bioresearch Monitoring | #1086865 |
| March 8, 2019 | University of Puerto Rico IRB | NAI | Bioresearch Monitoring | #1085358 |
| February 27, 2019 | Nestor Sanchez, M.D. | NAI | Bioresearch Monitoring | #1083440 |
| February 21, 2019 | Novartis Pharmaceuticals Corporation | NAI | Bioresearch Monitoring | #1084426 |
| February 1, 2019 | Hikma Pharmaceuticals USA, Inc. | NAI | Bioresearch Monitoring | #1079961 |
| January 8, 2019 | Daiichi Sankyo, Inc. | VAI | Bioresearch Monitoring | #1076061 |
| December 14, 2018 | Novartis Pharmaceuticals Corporation | VAI | Bioresearch Monitoring | #1074476 |
| November 16, 2018 | Akorn Operating Company LLC | NAI | Bioresearch Monitoring | #1076080 |
| November 2, 2018 | Pfizer, Inc. | NAI | Bioresearch Monitoring | #1075115 |
| October 19, 2018 | Frontage Clinical Services, Inc. | NAI | Bioresearch Monitoring | #1071677 |
| September 24, 2018 | PACIRA PHARMACEUTICALS | NAI | Bioresearch Monitoring | #1067078 |
| September 13, 2018 | Pernix Therapeutics Holdings, Inc. | VAI | Postmarket Surv. and Epidemiology | #1065745 |
Documents (24)
- EIR · Pfizer Inc. · January 8, 2021
- 483 · Immunomedics, Inc. · August 1, 2018
- 483 · AMKS TIME RELEASE LAB, LLC · June 17, 2013
- EIR · Huntingdon Life Sciences, Inc. · August 14, 2020
- EIR · Frontage Clinical Services, Inc.
- 483 · Immunomedics, Inc. · August 1, 2018
- EIR · Novartis Pharmaceuticals Corporation · March 2, 2017
- 483 · Eisai, Inc. · February 16, 2018
- 483 · Frontage Clinical Services, Inc. · May 20, 2014
- 483 · E. Jeffrey Greenberg, MD · May 30, 2018
- EIR · Novartis Pharmaceuticals Corporation · September 7, 2017
- EIR · Novartis Pharmaceuticals Corporation · January 24, 2017
- EIR · Merck Sharp and Dohme Corp. · August 16, 2013
- 483 · Colgate-Palmolive Company · May 30, 2019
- 483 · AMKS TIME RELEASE LAB, LLC · July 12, 2013
- 483 · Teva API, Inc. · July 18, 2017
- 483 · Novartis Pharmaceuticals Corporation · December 14, 2018
- EIR · Merck & Co. Inc · September 6, 2019
- 483 · Boehringer Ingelheim Pharmaceuticals, Inc. · December 12, 2019
- EIR · Pfizer Inc. · November 2, 2018
- EIR · Immunomedics, Inc. · August 1, 2018
- 483 · Mandeep S. Oberoi, M.D. · January 10, 2020
- EIR · AMKS TIME RELEASE LAB, LLC · July 12, 2013
- 483 · Novartis Pharmaceuticals Corporation · January 24, 2017
Frequently inspected with (9)
Person Information
Name
Peter R. Lenahan
Title
Regulatory Officer
Role
Regulatory Personnel
ID: c695dac2-5447-434b-801e-f95e6acf05f1
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.